Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score.

Literature DB >> 22547369

A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score.

Melina Verso, Giancarlo Agnelli, Sandro Barni, Giampietro Gasparini, Roberto LaBianca.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2012 PMID： 22547369 DOI： 10.1007/s11739-012-0784-y

Source DB: PubMed Journal: Intern Emerg Med ISSN： 1828-0447 Impact factor: 3.397

× No keyword cloud information.

5 in total

1. Venous thromboembolic disease.

Authors: Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal: J Natl Compr Canc Netw Date: 2011-07-01 Impact factor: 11.908

Review 2. Venous thromboembolism and cancer: a two-way clinical association.

Authors: G Agnelli
Journal: Thromb Haemost Date: 1997-07 Impact factor: 5.249

3. Development and validation of a predictive model for chemotherapy-associated thrombosis.

Authors: Alok A Khorana; Nicole M Kuderer; Eva Culakova; Gary H Lyman; Charles W Francis
Journal: Blood Date: 2008-01-23 Impact factor: 22.113

4. Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.

Authors: Giancarlo Agnelli; Gualberto Gussoni; Carlo Bianchini; Melina Verso; Mario Mandalà; Luigi Cavanna; Sandro Barni; Roberto Labianca; Franco Buzzi; Giovanni Scambia; Rodolfo Passalacqua; Sergio Ricci; Giampietro Gasparini; Vito Lorusso; Erminio Bonizzoni; Maurizio Tonato
Journal: Lancet Oncol Date: 2009-08-31 Impact factor: 41.316

5. Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study.

Authors: Sandro Barni; Roberto Labianca; Giancarlo Agnelli; Erminio Bonizzoni; Melina Verso; Mario Mandalà; Matteo Brighenti; Fausto Petrelli; Carlo Bianchini; Tania Perrone; Giampietro Gasparini
Journal: J Transl Med Date: 2011-10-20 Impact factor: 5.531

5 in total

89 in total

1. Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study.

Authors: Patrizia Ferroni; Silvia Riondino; Fiorella Guadagni; Mario Roselli
Journal: Haematologica Date: 2013-12 Impact factor: 9.941

Review 2. Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis.

Authors: Minh Phan; Sonia John; Ana I Casanegra; Suman Rathbun; Aaron Mansfield; Julie A Stoner; Alfonso J Tafur
Journal: J Thromb Thrombolysis Date: 2014 Impact factor: 2.300

3. Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.

Authors: Joanna L Sylman; Annachiara Mitrugno; Garth W Tormoen; Todd H Wagner; Parag Mallick; Owen J T McCarty
Journal: Converg Sci Phys Oncol Date: 2017-05-17

4. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.

Authors: Ingrid Pabinger; Nick van Es; Georg Heinze; Florian Posch; Julia Riedl; Eva-Maria Reitter; Marcello Di Nisio; Gabriela Cesarman-Maus; Noémie Kraaijpoel; Christoph Carl Zielinski; Harry Roger Büller; Cihan Ay
Journal: Lancet Haematol Date: 2018-06-07 Impact factor: 18.959

5. SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019).

Authors: A J Muñoz Martín; E Gallardo Díaz; I García Escobar; R Macías Montero; V Martínez-Marín; V Pachón Olmos; P Pérez Segura; T Quintanar Verdúguez; M Salgado Fernández
Journal: Clin Transl Oncol Date: 2020-01-24 Impact factor: 3.405

6. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).

Authors: Nicole M Kuderer; Marek S Poniewierski; Eva Culakova; Gary H Lyman; Alok A Khorana; Ingrid Pabinger; Giancarlo Agnelli; Howard A Liebman; Eric Vicaut; Guy Meyer; Frances A Shepherd
Journal: Oncologist Date: 2017-09-26